贝伐单抗与二极管激光治疗3期早产儿视网膜病变的比较。 - Suppr

Bevacizumab versus diode laser in stage 3 posterior retinopathy of prematurity.

作者信息

Moran Sarah, O'Keefe Michael, Hartnett Claire, Lanigan Bernadette, Murphy John, Donoghue Veronica

机构信息

Department of Ophthalmology, Children's University Hospital, Dublin 1, Ireland.

出版信息

Acta Ophthalmol. 2014 Sep;92(6):e496-7. doi: 10.1111/aos.12339. Epub 2014 Jan 16.

DOI:10.1111/aos.12339

PMID:24428792

Abstract

摘要

相似文献

Bevacizumab versus diode laser in stage 3 posterior retinopathy of prematurity.

Acta Ophthalmol. 2014 Sep;92(6):e496-7. doi: 10.1111/aos.12339. Epub 2014 Jan 16.

Intravitreal bevacizumab following laser therapy for severe retinopathy of prematurity.

J Pediatr Ophthalmol Strabismus. 2010 Aug 23;47 Online:e1-4. doi: 10.3928/01913913-20100818-09.

Retinal detachment despite aggressive management of aggressive posterior retinopathy of prematurity.

J Pediatr Ophthalmol Strabismus. 2010 Dec 22;47 Online:e1-4. doi: 10.3928/01913913-20101217-06.

Combined intravitreal bevacizumab injection and zone I sparing laser photocoagulation in patients with zone I retinopathy of prematurity.

Retina. 2014 Jan;34(1):77-82. doi: 10.1097/IAE.0b013e318296e26d.

Bilateral effect of unilateral bevacizumab injection in retinopathy of prematurity.

JAMA Ophthalmol. 2013 Aug;131(8):1099-101. doi: 10.1001/jamaophthalmol.2013.400.

Early refractive outcome after intravitreous bevacizumab for retinopathy of prematurity.

Arch Ophthalmol. 2012 Jun;130(6):800-1. doi: 10.1001/archophthalmol.2012.1.

Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings.

Ophthalmology. 2014 Nov;121(11):2212-9. doi: 10.1016/j.ophtha.2014.05.015. Epub 2014 Jul 4.

Current and future trends in treatment of severe retinopathy of prematurity.

Clin Perinatol. 2013 Jun;40(2):297-310. doi: 10.1016/j.clp.2013.02.005.

Combine intravitreal bevacizumab injection with laser treatment for aggressive posterior retinopathy of prematurity (AP-ROP).

J Med Assoc Thai. 2011 Aug;94 Suppl 3:S15-21.

Confluent diode laser coagulation: the gold standard of therapy for retinopathy of prematurity.

J Pediatr Ophthalmol Strabismus. 2015 Jan-Feb;52(1):43-51. doi: 10.3928/01913913-20141230-07.

引用本文的文献

Repeat Intravitreal Bevacizumab in a Very Low Birth Weight Infant with Recurrent ROP: 3-Year Follow-Up and Literature Review.

Case Rep Ophthalmol. 2025 Jun 13;16(1):521-527. doi: 10.1159/000546935. eCollection 2025 Jan-Dec.

Recurrence of Retinopathy of Prematurity Following Anti-vascular Endothelial Growth Factor (Anti-VEGF) Therapy: A Systematic Review and Meta-Analysis.

Cureus. 2024 Nov 8;16(11):e73286. doi: 10.7759/cureus.73286. eCollection 2024 Nov.

Pulmonary function in school-age children following intravitreal injection of bevacizumab for retinopathy of prematurity.

Sci Rep. 2022 Nov 5;12(1):18788. doi: 10.1038/s41598-022-22338-2.

Comparison of adverse events between intravitreal anti-VEGF and laser photocoagulation for treatment-requiring retinopathy of prematurity: a systematic review.

Int Ophthalmol. 2023 Mar;43(3):1027-1062. doi: 10.1007/s10792-022-02480-6. Epub 2022 Oct 10.

The role of anti-vascular endothelial growth factor in treatment of retinopathy of prematurity-a current review.

Eye (Lond). 2022 Aug;36(8):1532-1545. doi: 10.1038/s41433-021-01922-2. Epub 2022 Jan 11.

Description and management of retinopathy of prematurity reactivation after intravitreal antivascular endothelial growth factor therapy.

Curr Opin Ophthalmol. 2021 Sep 1;32(5):468-474. doi: 10.1097/ICU.0000000000000786.

Aggressive Posterior Retinopathy of Prematurity (APROP): LASER as the Primary Modality of Treatment.

J Ophthalmic Vis Res. 2021 Jul 29;16(3):400-407. doi: 10.18502/jovr.v16i3.9437. eCollection 2021 Jul-Sep.

VEGFR1 signaling in retinal angiogenesis and microinflammation.

Prog Retin Eye Res. 2021 Sep;84:100954. doi: 10.1016/j.preteyeres.2021.100954. Epub 2021 Feb 25.

Anti-Vascular Endothelial Growth Factor and the Evolving Management Paradigm for Retinopathy of Prematurity.

Asia Pac J Ophthalmol (Phila). 2018 May-Jun;7(3):136-144. doi: 10.22608/APO.201850. Epub 2018 May 29.

Comparison of efficacy between anti-vascular endothelial growth factor (VEGF) and laser treatment in Type-1 and threshold retinopathy of prematurity (ROP).

BMC Ophthalmol. 2018 Jan 30;18(1):19. doi: 10.1186/s12886-018-0685-6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Bevacizumab versus diode laser in stage 3 posterior retinopathy of prematurity.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献